Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase.
暂无分享,去创建一个
[1] Alan Ashworth,et al. A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Ian O Ellis,et al. Basal-like breast cancer: a critical review. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] K. Hess,et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] J Wade Harper,et al. The DNA damage response: ten years after. , 2007, Molecular cell.
[5] Heinrich Leonhardt,et al. Feedback-regulated poly(ADP-ribosyl)ation by PARP-1 is required for rapid response to DNA damage in living cells , 2007, Nucleic acids research.
[6] S. Narod,et al. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence , 2007, Clinical Cancer Research.
[7] Marc Tischkowitz,et al. Use of immunohistochemical markers can refine prognosis in triple negative breast cancer , 2007, BMC Cancer.
[8] R. Cress,et al. Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype , 2007, Cancer.
[9] C. Perou,et al. The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes , 2007, Clinical Cancer Research.
[10] M. Evans,et al. Lymphoblasts of women with BRCA1 mutations are deficient in cellular repair of 8,5'-Cyclopurine-2'-deoxynucleosides and 8-hydroxy-2'-deoxyguanosine. , 2007, Biochemistry.
[11] J. Weidhaas,et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Wen-Lin Kuo,et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.
[13] J. Reis-Filho,et al. Basal-like breast cancer and the BRCA1 phenotype , 2006, Oncogene.
[14] A. Nobel,et al. The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.
[15] A. Chatterjee,et al. The effect of p53‐RNAi and p53 knockout on human 8‐oxoguanine DNA glycosylase (hOgg1) activity , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] S. Powell,et al. The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break Repair , 2005, Molecular Cancer Research.
[17] Julian Peto,et al. Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype , 2005, Clinical Cancer Research.
[18] P. Storz. Reactive oxygen species in tumor progression. , 2005, Frontiers in bioscience : a journal and virtual library.
[19] Alan Ashworth,et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.
[20] Thomas Helleday,et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase , 2005, Nature.
[21] L. Chodosh,et al. Brca1-Deficient Murine Mammary Epithelial Cells have Increased Sensitivity to CDDP and MMS , 2004, Cell cycle.
[22] G. Achanta,et al. Role of p53 in Sensing Oxidative DNA Damage in Response to Reactive Oxygen Species-Generating Agents , 2004, Cancer Research.
[23] A. Gown,et al. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.
[24] William D. Foulkes,et al. Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer , 2004 .
[25] L. Bégin,et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. , 2004, Journal of the National Cancer Institute.
[26] J. Klaunig,et al. The role of oxidative stress in carcinogenesis. , 2004, Annual review of pharmacology and toxicology.
[27] Zhihui Feng,et al. Chk2 Phosphorylation of BRCA1 Regulates DNA Double-Strand Break Repair , 2004, Molecular and Cellular Biology.
[28] A. Hartman,et al. BRCA1 and p53: compensatory roles in DNA repair , 2003, Journal of Molecular Medicine.
[29] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Ford,et al. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair , 2002, Nature Genetics.
[31] M. J. van de Vijver,et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] S. Amundson,et al. Implication of p53 in base excision DNA repair: in vivo evidence , 2002, Oncogene.
[33] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[34] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[35] A. Jackson,et al. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. , 2001, Mutation research.
[36] Samuel H. Wilson,et al. A role for p53 in base excision repair , 2001, The EMBO journal.
[37] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[38] E. Berns,et al. Is TP53 dysfunction required for BRCA1-associated carcinogenesis? , 1999, Molecular and Cellular Endocrinology.
[39] V. Rotter,et al. Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery , 1999, FEBS letters.
[40] A. Moor,et al. Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation , 1999, Gene Therapy.
[41] M. Westerfield,et al. Characterization of paired tumor and non‐tumor cell lines established from patients with breast cancer , 1998, International journal of cancer.
[42] J. Peto,et al. p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours , 1998, Oncogene.
[43] J. Minna,et al. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. , 1998, Cancer research.
[44] J. T. Reardon,et al. In vitro repair of oxidative DNA damage by human nucleotide excision repair system: possible explanation for neurodegeneration in xeroderma pigmentosum patients. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[45] A. Collins,et al. Oxidative damage to DNA: do we have a reliable biomarker? , 1996, Environmental health perspectives.
[46] N. Polissar,et al. Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[47] M. Seller,et al. Unusual case of Smith-Lemli-Opitz syndrome "type II". , 1995, American journal of medical genetics.
[48] D. Easton,et al. Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.
[49] D. Bishop,et al. Breast and Ovarian Cancer Incidence in BRCA I -Mutation Carriers , 2007 .
[50] A. Hollestelle,et al. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. , 2006, Cancer research.
[51] M. Dusinska,et al. Comet assay in human biomonitoring studies: Reliability, validation, and applications , 1997, Environmental and molecular mutagenesis.
[52] D. Easton,et al. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.